Company Encyclopedia
View More
name
Translational Development Acquisition - Unit
TDACU.US
News
View More

Translational Development Acquisition - Unit | 10-Q: FY2025 Q3 Revenue: USD 0

LB filings·
US
TDACU
0.00%
LB filings·
US
TDACU
0.00%

Translational Development Acquisition - Unit | 10-Q: FY2025 Q1 EPS: USD 0.07

LB filings·
US
TDACU
0.00%
LB filings·
US
TDACU
0.00%
© 2025 Longbridge｜Disclaimer